BioHealth News Archive
Global Alliance Plans Internet for Genomes – MIT Technology Review
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across…
Read More
United Therapeutics (UTHR) Names co-CEO; Adjusts Martine Rothblatt’s Compensation Schedule
United Therapeutics (Nasdaq: UTHR) announced two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program. {iframe}http://www.streetinsider.com/Hot+Corp.+News/United+Therapeutics+(UTHR)+Names+co-CEO;+Adjusts+Martine+Rothblatts+Compensation+Schedule/10104086.html{/iframe}
Read More
University System of Maryland names Bob Caret as its fourth chancellor – Baltimore Business Journal
University of Massachusetts President Robert Caret will take over as University System of Maryland's fourth chancellor in July. {iframe}http://www.bizjournals.com/baltimore/news/2014/12/17/university-system-of-maryland-names-bob-caret-as.html?{/iframe}
Read More
Martine Rothblatt: She founded SiriusXM, a religion and a biotech. For starters. – The Washington Post
Let’s be clear: Martine Rothblatt is just plain more of a lawyer than anybody else in this town. The 60-year-old grandmother and CEO of…
Read More
FDA 2014 approvals outpace those of 2013 – Medical Marketing and Media
The FDA offered up an early retrospective of the 2014 year of approvals Friday with a rundown the regulator feels pretty good about. “Our…
Read MoreWhich health tech trends will make big bucks in 2015?
The world of technology is growing at a rapid pace, nothing new, but next year could involve some major cashing in for some health…
Read More
Evolva sells EV-035 Series to Emergent BioSolutions
Evolva Holding SA (“Evolva”, SIX: EVE) today announced that Emergent BioSolutions Inc. (“Emergent”, NYSE: EBS) has acquired Evolva’s anti-bacterial programme, the EV-035 series. The…
Read More
New Protective Ebola Suit Developed at Johns Hopkins University (VIDEO)
Healthcare workers treating Ebola victims are at a great danger of contracting the disease, as recent events in western Africa have shown. Currently available…
Read More
The Year in Medicine 2014: News That Made a Difference
Ebola dominated the news in the second half of the year. Other important news was the debate on maintenance of certification, the first baby…
Read More
Biocoding For Beginners – Co.Labs
Cathal Garvey used to work in cancer research. Now he is the scientific director of IndieBio, a biotech accelerator based in Cork, Ireland which…
Read More
Maryland is accepting applications to create economic development zones around colleges – Baltimore Business Journal
Maryland is not waiting for the new year or a new governor to start taking applications for a program intended to boost business development…
Read More
Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence Clinical Trials of ADXS-HPV in Combination With MedImmune’s MEDI4736 for the Treatment of HPV-Associated Cancers Nasdaq:ADXS
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
Read More
Univ. of Md. places high in world rankings for scientific research – The Diamondback : News
With new articles published in journals every week and scores of labs constantly at work, scientists at this university stay productive. And a new…
Read More
Human Cellular Models for Predicting Individual Responses to CFTR (Cystic Fibrosis Transmembrane Conductance Regulator)-Directed Therapeutics
NHLBI is soliciting applications from small businesses to develop and validate novel in vitro human cell-based tools for predicting the responses of individual patients…
Read More
New NHLBI Funding Opportunity: Stem Cell-Derived Blood Products for Therapeutic Use
Stem cell-derived blood and platelet products have the potential to meet critical medical needs. Remaining challenges exist in both the manufacturing process and additional…
Read More